Cargando…
Roles of ST2, IL‐33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention
This study investigated roles of serum ST2, IL‐33 and BNP in predicting major adverse cardiovascular events (MACEs) in acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI). Blood samples were collected from the included AMI patients (n = 180) who underwent PCI. All patien...
Autores principales: | Wang, Yan‐Peng, Wang, Jian‐Hua, Wang, Xiao‐Long, Liu, Jun‐Yi, Jiang, Fang‐Yun, Huang, Xiao‐Li, Hang, Jing‐Yu, Qin, Wei, Ma, Shi‐Xin, Zhang, Jie, Yuan, Min‐Jie, Li, Jing‐Bo, Lu, Zhi‐Gang, Wei, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661109/ https://www.ncbi.nlm.nih.gov/pubmed/28623858 http://dx.doi.org/10.1111/jcmm.13183 |
Ejemplares similares
-
Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015) -
NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
por: Qin, Zuoan, et al.
Publicado: (2021) -
Prognostic Value of Systemic Immune-Inflammation Index and NT-proBNP in Patients with Acute ST-Elevation Myocardial Infarction
por: Zhu, Yinghua, et al.
Publicado: (2023) -
Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022) -
Prediction models for major adverse cardiovascular events following ST-segment elevation myocardial infarction and subgroup-specific performance
por: Chen, Weiyao, et al.
Publicado: (2023)